This article is published as part of a supplement sponsored by Kidney Disease: Improving
Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of …

Antiplatelet therapy is the mainstay of pharmacologic treatment to prevent thrombotic or
ischemic events in patients with coronary artery disease treated with percutaneous coronary …

Background In patients with non–ST-segment elevation acute coronary syndrome
(NSTEACS), coronary pathology may range from structurally normal vessels to severe …

Aims Patients at high bleeding risk (HBR) represent a prevalent subgroup among those
undergoing percutaneous coronary intervention (PCI). Early aspirin discontinuation after a …

The 2021 American Heart Association/American College of Cardiology/American Society of
Echocardiography/American College of Chest Physicians/Society for Academic Emergency …

Background Standard modifiable cardiovascular risk factors (SMuRF), comprising diabetes,
hyperlipidemia, hypertension, and smoking, are used for risk stratification in acute coronary …

While there is a clear clinical benefit of oral anticoagulation in patients with atrial fibrillation
(AF) and venous thromboembolism (VTE) in reducing the risks of thromboembolism, major …

Diagnostic and therapeutic advances during the past decades have substantially improved
health outcomes for patients with acute coronary syndrome. Both age-related physiological …

Coronary computed tomography angiography (CTA) has shown great technological
improvements over the last 2 decades. High accuracy of CTA in detecting significant …

Aims Perioperative myocardial infarction/injury (PMI) following non-cardiac surgery is a
frequent cardiac complication. Better understanding of the underlying aetiologies and …